216 related articles for article (PubMed ID: 23333526)
1. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis.
Waidmann O; Brunner F; Herrmann E; Zeuzem S; Piiper A; Kronenberger B
J Hepatol; 2013 May; 58(5):956-61. PubMed ID: 23333526
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
[TBL] [Abstract][Full Text] [Related]
4. Role of Serum Soluble CD163 in the Diagnosis, Risk of Bleeding, and Prognosis of Gastro-Esophageal Varices in Cirrhotic Patients.
Fouad R; Hamza I; Khairy M; Elsharkawy M; Helmy AA
J Interferon Cytokine Res; 2017 Mar; 37(3):112-118. PubMed ID: 28282272
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
[TBL] [Abstract][Full Text] [Related]
6. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G
Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112
[TBL] [Abstract][Full Text] [Related]
7. Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.
Yang YY; Hou MC; Lin MW; Chen PH; Liao WC; Chu CJ; Lin HC
J Gastroenterol Hepatol; 2013 Jan; 28(1):112-21. PubMed ID: 22849380
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O
J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653
[TBL] [Abstract][Full Text] [Related]
9. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.
Holland-Fischer P; Grønbæk H; Sandahl TD; Moestrup SK; Riggio O; Ridola L; Aagaard NK; Møller HJ; Vilstrup H
Gut; 2011 Oct; 60(10):1389-93. PubMed ID: 21572121
[TBL] [Abstract][Full Text] [Related]
10. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
Møller HJ; Grønbaek H; Schiødt FV; Holland-Fischer P; Schilsky M; Munoz S; Hassanein T; Lee WM;
J Hepatol; 2007 Nov; 47(5):671-6. PubMed ID: 17629586
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
15. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
Eslam M; Ampuero J; Jover M; Abd-Elhalim H; Rincon D; Shatat M; Camacho I; Kamal A; Lo Iacono O; Nasr Z; Grande L; Banares R; Khattab MA; Romero-Gomez M
Ann Hepatol; 2013; 12(4):588-98. PubMed ID: 23813137
[TBL] [Abstract][Full Text] [Related]
16. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
[TBL] [Abstract][Full Text] [Related]
17. Critical illness-related corticosteroid insufficiency in cirrhotic patients with acute gastroesophageal variceal bleeding: risk factors and association with outcome*.
Tsai MH; Huang HC; Peng YS; Chen YC; Tian YC; Yang CW; Lien JM; Fang JT; Wu CS; Lee FY
Crit Care Med; 2014 Dec; 42(12):2546-55. PubMed ID: 25083978
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
[TBL] [Abstract][Full Text] [Related]
20. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
